Pioneers in immunoglobulin E testing

 

Since the discovery of IgE in 1967, Phadia has pioneered the development of in vitro test systems for allergy (immunoglobulin E). These IgE tests have been followed by tests for IgG and IgA antibodies, as well as other analytes with applications in asthma, celiac disease and autoimmunity.

In addtion, our ImmunoCAP testing system has revolutionized the level of automation and speed which these tests are processed. Based on the high binding capacity and solid phase technology, ImmunoCAP tests are both highly sensitive and highly specific.

For allergy testing in particular, ImmunoCAP has significantly increased diagnostic efficiency compared with previously available methods.

 

To learn more about our methods, choose from the drop-down list above.